Tumour vasculature as a target for anticancer therapy
- 30 June 2000
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 26 (3), 191-204
- https://doi.org/10.1053/ctrv.1999.0158
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470New England Journal of Medicine, 1998
- Expression of type IV collagenase correlates with the expression of vascular endothelial growth factor in primary non-small cell lung cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude miceInternational Journal of Cancer, 1997
- Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.Journal of Clinical Investigation, 1997
- Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic MiceJNCI Journal of the National Cancer Institute, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Growth factor control of extracellular proteolysisCell Differentiation and Development, 1990
- Proteolytic balance and capillary morphogenesisCell Differentiation and Development, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990